Group 6E: HR+ Breast Cancer; Hormone Therapy

Thursday, Dec 15 6:00 pm – 7:30 pm Eastern Time (US/New York)

Poster #P1-02-03

Real world treatment patterns of adjuvant endocrine therapy and ovarian suppression in premenopausal HR+/HER2+ breast cancer

Poster author Jasmine Sukumar, M.D. is also the scientist for this session

Poster #P3-01-13:

Palbociclib, ribociclib and abemaciclib in real-world data: risk of disease progression on first-line treatment of metastatic breast cancer

Mentor: Katie Edick

Katie Edick has been living with metastatic breast cancer (MBC) since 2016.  She has been a pediatric occupational therapist for 21 years.

Katie has volunteered with Little Pink Houses of Hope leading yearly retreats for families going through breast cancer. She provides mentoring to other MBC patients through Imerman Angels. Katie is engaging more with patient advocacy through sharing her story on local news programs, senate hearing committees, and podcasts to help educate and advocate for legislation and research to support families going through a breast cancer diagnosis. Currently, she is the social media coordinator for the Michigan Breast Cancer Coalition. She sits on two different workgroup committees in Michigan’s Department of Health & Human Services for young women with breast cancer; the advisory committee and the metastatic breast cancer committee. She attended the NBCC Advocate Leadership Summit and engaged with local legislators during that campaign, and has attended the annual Metastatic Breast Cancer Research Conference for three years. Check out her blog at

Twitter: @KatieEdick

Scientist: Jasmine Sukumar, M.D.

Dr. Jasmine Sukumar completed the dual BA/MD program at the University of Missouri-Kansas City followed by internal medicine residency at the University of Texas Southwestern Medical Center in Dallas, Texas. She subsequently joined The Ohio State University (OSU) James Comprehensive Cancer Center to embark upon her medical oncology fellowship. Additionally, she received breast cancer focused subspecialty training through the Breast Oncology Fellowship Program at the Stefanie Spielman Comprehensive Breast Center and graduated from the advanced breast cancer fellowship at OSU in 2021. During her postgraduate training she was awarded an intramural grant (Pelotonia) to support a postdoctoral fellowship year with an emphasis in cancer control and metabolism. She has published in peer reviewed journals such as Cancers and Breast Cancer Research and Treatment and presents at national conferences. She is currently an Assistant Professor at MD Anderson Cancer Center as a breast medical oncologist and clinical investigator.

Her research focuses on energy balance as a modifiable risk factor for health promotion in breast cancer survivors. Specifically, she investigates obesity, lifestyle behaviors, and inflammation as risk factors for breast carcinogenesis. She was accepted to the 2021 Transdisciplinary Research on Energetics and Cancer (TREC) Workshop, an NIH-funded research training and mentorship program through the Yale School of Public Health for early career investigators in energetics and cancer transdisciplinary research. She aims to conduct innovative personalized interventions for improvement in metabolic health and cancer risk reduction.

Twitter: @JasmineSukumar